- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05894473
Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease
Comparison of the Effects of Telerehabilitation-Based Motor and Cognitive Dual-Task Exercise in Patients With Parkinson's Disease - A Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The dual-task (DT) methodology aims to perform two tasks simultaneously. There is no study in which motor and cognitive dual-task exercises are given together and followed up remotely in elderly individuals with PD.
Therefore, it was aimed to compare the effects of telerehabilitation method and motor and cognitive dual-task exercises on cognitive function, balance, walking, fall risk and quality of life in individuals with Parkinson's Disease.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey (Türkiye)
- Yeditepe University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Being diagnosed with idiopathic Parkinson's Disease
- Getting at least 21 points from the Montreal Cognitive Assessment Scale test
- Stability of drug therapy taken in the last 1 month
- Being in the "ten" period of the patients
- Being able to walk independently on flat ground (3 and above according to Functional Ambulation Classification)
Exclusion Criteria:
• Serious hearing or vision problems
- Having other neurological, cardiovascular or orthopedic disorders that may prevent walking
- Any other neurological disorder (eg dementia, cerebrovascular disease)
- Having an education level of less than 5 years
- Patients with a pacemaker
- Having vascular lower extremity pathologies
- Not having internet access with a smart phone or computer
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Motor-Motor Dual Task Training Exercises
Motor-Motor Dual Task Physical Exercises will be given to the participants
|
Only physical exercise and motor dual tasks will be given
|
|
Active Comparator: Cognitive-Motor Dual Task Training Exercises
Cognitive-Motor Dual Task Physical Exercises will be given to the participants
|
Only physical exercise and motor dual tasks will be given
|
|
Active Comparator: Structured exercise program
Physical exercise will be given to the participants
|
Only physical exercise and motor dual tasks will be given
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Parkinson's Disease Quality of Life Questionnaire
Time Frame: 8 weeks
|
Parkinson's Disease Quality of Life Questionnaire
|
8 weeks
|
|
Montreal Cognitive Assessment Scale (MoCA)
Time Frame: 8 weeks
|
Montreal Cognitive Assessment Scale (MoCA)
|
8 weeks
|
|
Berg Balance Scale (BBS)
Time Frame: 8 weeks
|
Berg Balance Scale (BBS)
|
8 weeks
|
|
10 meter walking speed test
Time Frame: 8 weeks
|
10 meter walking speed test
|
8 weeks
|
|
Timed Up And Go Test
Time Frame: 8 weeks
|
Timed Up And Go Test
|
8 weeks
|
|
Fall Efficiency Scale - International
Time Frame: 8 weeks
|
Fall Efficiency Scale - International
|
8 weeks
|
|
Five Times Sit to Stand Test
Time Frame: 8 weeks
|
Five Times Sit to Stand Test
|
8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Yeditepe University, Yeditepe University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 60
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Parkinson Disease
-
Bezmialem Vakif UniversityRecruitingParkinson Disease | Parkinson | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseTurkey (Türkiye)
-
CND Life SciencesDigestive Disease Associates of CTRecruitingParkinson Disease | Parkinson | PARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Neuron23 Inc.Roche Diagnostic Ltd.; Qiagen Manchester LimitedRecruitingParkinson Disease | Parkinson | Idiopathic Parkinson Disease | Parkinson Disease, Idiopathic | Early Parkinson Disease (Early PD)United States, Spain, Israel, Poland, Italy, United Kingdom
-
San Francisco Neurology and Sleep CenterNot yet recruitingPARKINSON DISEASE (Disorder) | Parkinson s DiseaseUnited States
-
Haukeland University HospitalUniversity of Bergen; SPARK NSRecruitingParkinson Disease (PD) | Parkinson s DiseaseNorway
-
CND Life SciencesOregon Health and Science UniversityRecruitingParkinson Disease | Parkinson | Parkinson's Disease and Parkinsonism | PARKINSON DISEASE (Disorder)United States
-
Università degli Studi dell'InsubriaUniversidade Nova de Lisboa; Associazione Parkinson Insubria (AsPI), Section... and other collaboratorsRecruitingParkinson Disease | Parkinson | Parkinson Disease, Idiopathic | PARKINSON DISEASE (Disorder)Italy
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedParkinson Disease 6, Early-Onset | Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human | Parkinson Disease Autosomal Recessive, Early Onset | Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1United States
-
Duke UniversityMedical University of South Carolina; Massachusetts General Hospital; Mayo Clinic and other collaboratorsNot yet recruitingGut Microbiota | Gut Microbiome | Parkinson Disease (PD) | PARKINSON DISEASE (Disorder) | Prodromal Parkinsons DiseaseUnited States
-
ProgenaBiomeWithdrawnParkinson Disease | Parkinsons Disease With Dementia | Parkinson-Dementia Syndrome | Parkinson Disease 2 | Parkinson Disease 3 | Parkinson Disease 4United States
Clinical Trials on Motor-Motor Dual Task Physical Exercises
-
Fenerbahce UniversityRecruitingParkinson DiseaseTurkey
-
safia Darweesh halwshCompleted
-
University of PlymouthRecruiting
-
George Washington UniversityTerminated
-
Istanbul University - CerrahpasaRecruitingMental RetardationTurkey
-
Kutahya Health Sciences UniversityCompletedExercise | Cognitive Function | Healthy Participants | Motor Activity | Cognitive Rehabilitation | Balance, Postural | Multi-Tasking Behavior | Imagery, Psychotherapy | Stroop Test | Cognitive TestTurkey
-
University GhentUniversity Hospital, GhentRecruiting
-
Istanbul University - CerrahpasaNot yet recruiting
-
Riphah International UniversityActive, not recruiting
-
University Hospital TuebingenParkinson StiftungNot yet recruitingMild Cognitive Impairment (MCI) | PARKINSON DISEASE (Disorder)Germany